SPERMATOGENIC CELLS ON DEFINED SUBSTRATES FOR TOXICOLOGY

Information

  • Research Project
  • 3499895
  • ApplicationId
    3499895
  • Core Project Number
    R43HD027784
  • Full Project Number
    1R43HD027784-01A1
  • Serial Number
    27784
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/15/1991 - 33 years ago
  • Project End Date
    3/15/1992 - 32 years ago
  • Program Officer Name
  • Budget Start Date
    9/15/1991 - 33 years ago
  • Budget End Date
    3/15/1992 - 32 years ago
  • Fiscal Year
    1991
  • Support Year
    1
  • Suffix
    A1
  • Award Notice Date
    9/16/1991 - 33 years ago
Organizations

SPERMATOGENIC CELLS ON DEFINED SUBSTRATES FOR TOXICOLOGY

The goal of our Phase I research program is to establish culture conditions that will maintain differentiated cell functions in rat Sertoli cell- spermatogenic cell co-cultures for extended times, using defined substrates, and serum-free medium, and functional assays. The cultures will be evaluated for suitability for toxicological testing and reproductive hormone assays using as model toxicants chemotherapeutic drugs with known testicular toxicity. The defined substrates will be based on collagen-glycosaminoglycan crosslinked copolymers. Both increased longevity and additional stages of differentiation are important objectives for toxicological assays because they allow for better standardization of cultures, longer contact times for agents to be tested, identification of particularly sensitive spermatogenic cell types and differentiation substages, and greater sensitivity and range in observing toxic endpoints. Our data may also be of clinical significance since short term assays of effects of chemotherapeutic drugs on spermatogenic cell differentiation may be useful in predicting the potential of chemical-induced sterility in cancer patients of reproductive age. The use of drugs with lower toxicity to testicular cells may then be considered in these patients. Knowledge gained from our work may also have value in the understanding and treatment of human infertility.

IC Name
EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT
  • Activity
    R43
  • Administering IC
    HD
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    864
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    SSS
  • Study Section Name
  • Organization Name
    BIOMAT CORPORATION
  • Organization Department
  • Organization DUNS
  • Organization City
    BELMONT
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    02178
  • Organization District
    UNITED STATES